Only 10% of organizations expect in-person work all of the time.

A troublesome 2 in 3 employees would change their jobs for better benefits, and 46% of workers are actively considering a job change in 2024.

Bristol Myers Squibb, Novo Nordisk, Novartis and Johnson & Johnson presented their arguments on Thursday in New Jersey district court, just a week after a similar AstraZeneca suit was dismissed by a federal judge in Delaware.

For now, insurers and employers are still not required to cover certain free preventive care services, such as cancer screenings and HIV-preventing medications, until the federal appeals court makes its decision later this year.

The Centers for Medicare & Medicaid Services is assisting providers that are struggling financially during what the AMA calls the "most significant and consequential incident of its kind against the U.S. health-care system in history,"

President Joe Biden made health care affordability a centerpiece of Thursday evening's address, announcing he is calling on Congress to expand the $2,000 out-of-pocket Medicare prescription cap to all private insurance.

Just 3% of health system executives and 7% of health plan executives have a positive outlook for 2024.

Cost Plus Drugs CEO Mark Cuban was invited to the White House, along with other business and government leaders, to discuss PBM reform, while a trade group for pharmacy benefit managers said they were not invited.